823 related articles for article (PubMed ID: 19409642)
1. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
2. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
3. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis.
Chen X; Xu F; Wang Y; Pan Y; Lu D; Wang P; Ying K; Chen E; Zhang W
Cancer; 2007 Aug; 110(4):835-44. PubMed ID: 17599760
[TBL] [Abstract][Full Text] [Related]
4. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
5. Breath analysis in non small cell lung cancer patients after surgical tumour resection.
Poli D; Goldoni M; Caglieri A; Ceresa G; Acampa O; Carbognani P; Rusca M; Corradi M
Acta Biomed; 2008; 79 Suppl 1():64-72. PubMed ID: 18924311
[TBL] [Abstract][Full Text] [Related]
6. Determination of volatile organic compounds as biomarkers of lung cancer by SPME-GC-TOF/MS and chemometrics.
Rudnicka J; Kowalkowski T; Ligor T; Buszewski B
J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Nov; 879(30):3360-6. PubMed ID: 21982505
[TBL] [Abstract][Full Text] [Related]
7. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
8. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD.
Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ
Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643
[TBL] [Abstract][Full Text] [Related]
9. Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS.
Poli D; Goldoni M; Corradi M; Acampa O; Carbognani P; Internullo E; Casalini A; Mutti A
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2643-51. PubMed ID: 20149763
[TBL] [Abstract][Full Text] [Related]
10. Investigation of volatile biomarkers in lung cancer blood using solid-phase microextraction and capillary gas chromatography-mass spectrometry.
Deng C; Zhang X; Li N
J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Sep; 808(2):269-77. PubMed ID: 15261821
[TBL] [Abstract][Full Text] [Related]
11. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
12. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study.
Phillips M; Gleeson K; Hughes JM; Greenberg J; Cataneo RN; Baker L; McVay WP
Lancet; 1999 Jun; 353(9168):1930-3. PubMed ID: 10371572
[TBL] [Abstract][Full Text] [Related]
13. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
14. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
15. In situ detection of lung cancer volatile fingerprints using bronchoscopic air-sampling.
Santonico M; Lucantoni G; Pennazza G; Capuano R; Galluccio G; Roscioni C; La Delfa G; Consoli D; Martinelli E; Paolesse R; Di Natale C; D'Amico A
Lung Cancer; 2012 Jul; 77(1):46-50. PubMed ID: 22264635
[TBL] [Abstract][Full Text] [Related]
16. Determination of volatile biomarkers for apoptosis and necrosis by solid-phase microextraction-gas chromatography/mass spectrometry: a pharmacometabolomic approach to cisplatin's cytotoxicity to human lung cancer cell lines.
Pyo JS; Ju HK; Park JH; Kwon SW
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Dec; 876(2):170-4. PubMed ID: 19027370
[TBL] [Abstract][Full Text] [Related]
17. [Volatile hydrocarbons in exhaled air: preliminary data on the characteristic profile associated with lung tumors].
Corradi M; Poli D; Selis L; Carbognani P; Acampa O; Iavicoli S; Rusca M; Mutti A
G Ital Med Lav Ergon; 2003; 25 Suppl(3):59-60. PubMed ID: 14979083
[TBL] [Abstract][Full Text] [Related]
18. Exhaled breath analysis: novel approach for early detection of lung cancer.
Chan HP; Lewis C; Thomas PS
Lung Cancer; 2009 Feb; 63(2):164-8. PubMed ID: 18599152
[TBL] [Abstract][Full Text] [Related]
19. Release of volatile organic compounds from the lung cancer cell line NCI-H2087 in vitro.
Sponring A; Filipiak W; Mikoviny T; Ager C; Schubert J; Miekisch W; Amann A; Troppmair J
Anticancer Res; 2009 Jan; 29(1):419-26. PubMed ID: 19331181
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers.
McCulloch M; Jezierski T; Broffman M; Hubbard A; Turner K; Janecki T
Integr Cancer Ther; 2006 Mar; 5(1):30-9. PubMed ID: 16484712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
